Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Gao Y, Souza-Fonseca-Guimaraes F, Bald T, Ng SS, Young A, Ngiow SF, Rautela J, Straube J, Waddell N, Blake SJ, Yan J, Bartholin L, Lee JS, Vivier E, Takeda K, Messaoudene M, Zitvogel L, Teng MWL, Belz GT, Engwerda CR, Huntington ND, Nakamura K, Hölzel M, Smyth MJ.
Gao Y, et al. Among authors: blake sj.
Nat Immunol. 2024 May;25(5):925-926. doi: 10.1038/s41590-024-01799-9.
Nat Immunol. 2024.
PMID: 38514890
No abstract available.